SEC Filing Details
Document Details
Form
Filing Date
Sep 27, 2020
Document Date
Sep 21, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.
Filer
BIOGEN INC.